TP53 somatic mutation is associated with aging, is present in 4% of CH and is believed to play a vital role in CH development along with other associated gene mutations in DNMT3A, TET2, ASXL1, SRSF2, CBL, and SF3B1. The gene discussed is SRSF2; the disease is cyclic hematopoiesis.